The serotonin transporter in Alzheimer's and Parkinson's disease

55Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The etiology of late-onset Alzheimer's disease (AD) and idiopathic Parkinson's disease (PD) is not known. In both disorders there is an extensive degeneration of serotonergic neurons, with corresponding losses of the serotonin (5HT) transporter (5HTT), which is responsible for the reuptake of 5HT from the synaptic cleft. An increasing body of evidence indicates that allelic variation of the 5HTT gene promoter (5HTT gene-linked polymorphic region, 5HTTLPR) determines high or low 5HT uptake in normal human brain. Association studies show that the low-activity allele of the 5HTTLPR is a risk factor for late-onset AD. In PD, the 5HTTLPR influences the risk of developing depression, a common symptom in PD patients. A compromised serotonergic system thus plays an important role in the pathophysiology of both AD and PD.

Cite

CITATION STYLE

APA

Mössner, R., Schmitt, A., Syagailo, Y., Gerlach, M., Riederer, P., & Lesch, K. P. (2000). The serotonin transporter in Alzheimer’s and Parkinson’s disease. In Journal of Neural Transmission, Supplement (pp. 345–350). Springer Wien. https://doi.org/10.1007/978-3-7091-6301-6_24

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free